Latest: Fortis Healthcare Ltd Q1 FY27 results →All Q4 FY26 results →
FH

Fortis Healthcare Ltd

Q4 FY26Healthcare Services

Fortis Healthcare Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Price₹907
Market cap₹69.8K Cr
P/E66.1
Updated23 Aug 2026
Read3 min read

The short version

Hospital business revenue expected to grow 15%+ organically in FY27 (Page 12). Fortis Healthcare expects 15%+ revenue growth in the hospital business for FY27 with 150 bps margin improvement.

From Fortis Healthcare Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Hospital business revenue expected to grow 15%+ organically in FY27 (Page 12).
  • Diagnostics revenue growth targeting double-digit, currently improving from 8.5% to aiming for 10%+ (Page 8).
  • Volume growth in diagnostics expected around 5% with a 70:30 split of volume to value growth (Page 8).
  • Expansion plans include commissioning of 500+ beds via brownfield projects in FY27, supporting revenue growth (Page 14).
  • New facilities and brownfield expansions in Mohali, Shalimar Bagh, Amritsar, Bangalore, and Mulund to drive future capacity and revenue increases (Page 15).

2 more points from Fortis Healthcare Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Fortis Healthcare Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • In FY26, Fortis Healthcare incurred approximately INR 700 crores in capital expenditure focused on capacity expansion and enhancement of medical infrastructure.
  • Over the next 4 years, the company plans to add around 1,800 beds through brownfield expansions.
  • For FY27, the target is to add more than 400 beds, including a new tower at FMRI expected to be operational within weeks, along with additions at Noida, Manesar, Amritsar, and FHKI Kolkata.
  • Annual capex guidance from FY27 to FY29 is around INR 900 crores, with approximately 60% allocated toward maintenance capex and the remainder toward growth capex.

2 more points from Fortis Healthcare Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 2
5
Rev 2Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Fortis Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Fortis Healthcare Ltd said on order book & pipeline — free account, 30 seconds.

Fortis Healthcare Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.4K Cr, net profit ₹271 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Suven Life Scie. (Q4 FY26)

    The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su

  • Invicta Diagnostic Ltd (Q4 FY26)

    Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…

  • KMC Speciality Hospitals (India) Ltd (Q4 FY26)

    Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…

  • Star Imaging and Path Lab Ltd (Q4 FY26)

    Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Fortis Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Fortis Healthcare Ltd Q4 FY26 results?

Hospital business revenue expected to grow 15%+ organically in FY27 (Page 12). Fortis Healthcare expects 15%+ revenue growth in the hospital business for FY27 with 150 bps margin improvement.

What is Fortis Healthcare Ltd share price analysis?

Fortis Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 66.1 with a market cap of ₹69,834 Cr. Investors should review the full earnings analysis for detailed insights.

Is Fortis Healthcare Ltd planning capital expenditure?

In FY26, Fortis Healthcare incurred approximately INR 700 crores in capital expenditure focused on capacity expansion and enhancement of medical infrastructure.

Keep Fortis Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.